Tag Archive for: life sciences

Virtual Policy Briefing: Exploring the Intersection of Vocational-Technical Education and the Life Sciences Sector

Massachusetts is the nation’s leader in vocational-technical schooling and home to the most dynamic life sciences sector in America. We invite you to join us for a webinar on the nexus between the Bay State’s educational, life science, and competitive human capital needs in the 21st-century global economy.

Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.

Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”

Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer Programs

A new white paper, "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Copayment Assistance Programs," examines how the way these programs are implemented is having negative impacts on patients living with serious diseases.

What’s going on with the economy in Cambridge?

/
Dubbed the city of squares, Cambridge, a leading innovation center,…

Avak Kahvejian on How Immigrants Drive Innovation

This week on JobMakers, host Denzil Mohammed talks with Dr. Avak Kahvejian, an inventor, entrepreneur and CEO as well as general partner at Flagship Pioneering, a life sciences venture capital company in Cambridge, Massachusetts.

The Promise and Challenges of Rare Cancer Treatments

Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum. 

Report: Rare Disease Patients Hurt by “One-Size-Fits-All” ICER Framework

/
This op-ed appeared in ICERWatch on June 26, 2019. The Institute…

Putting a Price on Life: The Coming Fight Over Government Rationing of Medical Care

/
This article appeared on The Mackinac Center for Public Policy…

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

/
This article by Chris Rochester appeared in The MacIver Institute…

Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

/
This op-ed by William Smith and Adam Crepeau appeared in the…

HHS Secretary Alex Azar doesn’t want drug access to become an equation

/
This op-ed by William Smith appeared in the Washington Examiner…

The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews

/
This op-ed by William Smith appeared in STAT News on February…

Baker’s Orwellian drug pricing policy

/
This op-ed by William Smith appeared in Commonwealth Magazine…

Study: Tax Credits Would Help MA Stem Loss of R&D Market Share

$1 billion life sciences initiative has created just 571 jobs,…